IRIS

GIULIANO, MARIO

GIULIANO, MARIO  

DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA  

Mostra records
Risultati 1 - 20 di 115 (tempo di esecuzione: 0.025 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
FOLFOX-4 in pre-treated patients with advanced transitional cell carcinoma of the bladder. 1.1 Articolo in rivista 2004 Giuseppe Di, Lorenzo; Riccardo, Autorino; Antonio, Giordano; Giuliano, Mario; Massimo, D'Armiento; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
Combination of bevacizumab and docetaxel in docetaxel-pretreated hormone-refractory prostate cancer: a phase 2 study. 1.1 Articolo in rivista 2008 Di Lorenzo, G; Figg, Wd; Fossa, Sd; Mirone, Vincenzo; Autorino, R; Longo, Nicola; Imbimbo, Ciro; Perdonà, S; Giordano, A; Giuliano, Mario; Labianca, R; DE PLACIDO, Sabino
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis 1.1 Articolo in rivista 2009 DI LORENZO, Giuseppe; Autorino, R.; Bruni, G.; Cartenì, G.; Ricevuto, E.; Tudini, M.; Ficorella, C.; Romano, C.; Aieta, M.; Giordano, Antonio; Giuliano, Mario; Gonnella, A.; De Nunzio, C.; Rizzo, M.; Montesarchio, V.; Ewer, M.; DE PLACIDO, Sabino
Combination of bevacizumab and docetaxel in docetaxel-pretreated hormone-refractory prostate cancer: a phase 2 study. 1.1 Articolo in rivista 2008 Giuseppe Di, Lorenzo; William D., Figg; Sophie D., Fossa; Vincenzo, Mirone; Riccardo, Autorino; Nicola, Longo; Ciro, Imbimbo; Sisto, Perdonà; Antonio, Giordano; Giuliano, Mario; Roberto, Labianca; DE PLACIDO, Sabino
Phase II trial of gemcitabine, prednisone, and zoledronic acid in pretreated patients with hormone refractory prostate cancer. 1.1 Articolo in rivista 2007 Giuseppe Di, Lorenzo; Riccardo, Autorino; Giuliano, Mario; Emilio, Morelli; Antonio, Giordano; Giorgio, Napodano; Aniello, Russo; Giuseppe, Benincasa; Massimino, D'Armiento; Vincenzo, Altieri; DE PLACIDO, Sabino
Biological mechanisms and clinical implications of endocrine resistance in breast cancer. 1.1 Articolo in rivista 2011 Giuliano, Mario; Schifp, R; Osborne, Ck; Trivedi, Mv
Die and let live: harnessing BikDD to combat breast cancer stem cells. 1.1 Articolo in rivista 2012 Giuliano, Mario; Trivedi, Mv; Schiff, R.
Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis. 1.1 Articolo in rivista 2015 Giuliano, Mario; Herrera, S; Christiny, P; Shaw, C; Creighton, Cj; Mitchell, T; Bhat, R; Zhang, X; Mao, S; Dobrolecki, Le; Al Rawi, A; Chen, F; Veneziani, BIANCA MARIA; Zhang, X; Hilsenbeck, Sg; Contreras, A; Gutierrez, C; Jeselsohn, Rm; Rimawi, Mf; Osborne, C; Lewis, Mt; Schiff, R; Trivedi, M. V.
Continuing trastuzumab beyond disease progression: outcomes analysis in patients with metastatic breast cancer. 1.1 Articolo in rivista 2008 Cancello, G.; Montagna, E.; D'Agostino, D.; Giuliano, Mario; Giordano, A.; Di Lorenzo, G.; Plaitano, M.; DE PLACIDO, Sabino; DE LAURENTIIS, Michelino
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials 1.1 Articolo in rivista 2008 DE LAURENTIIS, Michelino; Cancello, G.; D'Agostino, D.; Giuliano, Mario; Giordano, A.; Montagna, E.; Lauria, Rossella; Forestieri, Valeria; Esposito, A.; Silvestro, L.; Pennacchio, R.; Criscitiello, C.; Montanino, A.; Limite, Gennaro; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
Artificial neural network analysis of circulating tumor cells in metastatic breast cancer patients. 1.1 Articolo in rivista 2011 Giordano, A; Giuliano, Mario; DE LAURENTIIS, Michelino; Eleuteri, A; Iorio, F; Tagliaferri, R; Hortobagyi, Gn; Pusztai, L; DE PLACIDO, Sabino; Hess, K; Cristofanilli, M; Reuben, Jm
Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer. 1.1 Articolo in rivista 2012 De Giorgi, U; Mego, M; Scarpi, E; Giuliano, Mario; Giordano, A; Reuben, Jm; Valero, V; Ueno, Nt; Hortobagyi, Gn; Cristofanilli, M.
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment. 1.1 Articolo in rivista 2011 Giuliano, Mario; Giordano, A; Jackson, S; Hess, Kr; De Giorgi, U; Mego, M; Handy, Bc; Ueno, Nt; Alvarez, Rh; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Valero, V; Hortobagyi, Gn; Reuben, Jm; Cristofanilli, M.
Therapeutic potential of the dual EGFR/HER2?inhibitor AZD8931 in circumventing endocrine resistance. 1.1 Articolo in rivista 2014 Morrison, G; Fu, X; Shea, M; Nanda, S; Giuliano, Mario; Wang, T; Klinowska, T; Osborne, Ck; Rimawi, Mf; Schiff, R.
Bidirectional Crosstalk between the Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 Signaling Pathways in Breast Cancer: Molecular Basis and Clinical Implications. 1.1 Articolo in rivista 2013 Giuliano, Mario; Trivedi, Mv; Schiff, R.
Targeting HER2 as a therapeutic strategy for breast cancer: a paradigmatic shift of drug development in oncology. 1.1 Articolo in rivista 2005 DE LAURENTIIS, Michelino; Cancello, G; Zinno, L; Montagna, E; Malorni, L; Esposito, A; Pennacchio, R; Silvestro, L; Giuliano, Mario; Giordano, A; Caputo, F; Accurso, A; DE PLACIDO, Sabino
Circulating tumor cells in newly diagnosed inflammatory breast cancer 1.1 Articolo in rivista 2015 Mego, Michal; Giordano, Antonio; De Giorgi, Ugo; Masuda, Hiroko; Hsu, Limin; Giuliano, Mario; Fouad, Tamer M; Dawood, Shaheenah; Ueno, Naoto T; Valero, Vicente; Andreopoulou, Eleni; Alvarez, Ricardo H; Woodward, Wendy A; Hortobagyi, Gabriel N; Cristofanilli, Massimo; Reuben, James M.
Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination 1.1 Articolo in rivista 2014 Giuliano, Mario; Giordano, Antonio; Jackson, Summer; De Giorgi, Ugo; Mego, Michal; Cohen, Evan N; Gao, Hui; Anfossi, Simone; Handy, Beverly C; Ueno, Naoto T; Alvarez, Ricardo H; DE PLACIDO, Sabino; Valero, Vicente; Hortobagyi, Gabriel N; Reuben, James M; Cristofanilli, Massimo
Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapy. 1.1 Articolo in rivista 2011 Giordano, A; Giuliano, Mario; DE LAURENTIIS, Michelino; Arpino, Grazia; Jackson, S; Handy, Bc; Ueno, Nt; Andreopoulou, E; Alvarez, Rh; Valero, V; DE PLACIDO, Sabino; Hortobagyi, Gn; Reuben, Jm; Cristofanilli, M.
Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase 1.1 Articolo in rivista 2014 Fu, Xiaoyong; Creighton, Chad J.; Biswal, Nrusingh C.; Kumar, Vijetha; Shea, Martin; Herrera, Sabrina; Contreras, Alejandro; Gutierrez, Carolina; Wang, Tao; Nanda, Sarmistha; Giuliano, Mario; Morrison, Gladys; Nardone, Agostina; Karlin, Kristen L.; Westbrook, Thomas F.; Heiser, Laura M.; Anur, Pavana; Spellman, Paul; Guichard, Sylvie M.; Smith, Paul D.; Davies, Barry R.; Klinowska, Teresa; Lee, Adrian V.; Mills, Gordon B.; Rimawi, Mothaffar F.; Hilsenbeck, Susan G.; Gray, Joe W.; Joshi, Amit; Osborne, C. K.; Schiff, Rachel